| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 13 | |
| #2 | EPO (European Patent Office) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology | |
| #4 | Measurement | |
| #5 | Machines | |
| #6 | Computer technology | |
| #7 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Climate change adaptation technologies | |
| #3 | Therapeutic chemical compounds | |
| #4 | Peptides | |
| #5 | Microorganisms | |
| #6 | Analysing materials | |
| #7 | Unspecified technologies | |
| #8 | Fermentation | |
| #9 | Healthcare informatics | |
| #10 | Diagnosis and surgery |
| # | Name | Total Patents |
|---|---|---|
| #1 | Dubois Doria R | 3 |
| #2 | Oaks Edwin V | 3 |
| #3 | Hoke Charles H | 3 |
| #4 | Eckels Kenneth H | 3 |
| #5 | Innis Bruce L | 3 |
| #6 | Putnak Joseph R | 3 |
| #7 | Lanar David E | 2 |
| #8 | Dutta Sheetij | 2 |
| #9 | Lyon Jeffrey A | 2 |
| #10 | Turbyfill Kevin Ross | 2 |
| Publication | Filing date | Title |
|---|---|---|
| EP3183002A2 | Monoclonal antibodies for treatment of microbial infections | |
| AU2006214694A1 | A plasmodium vivax hybrid circumsporozoite protein and vaccine | |
| AU2003228440A1 | Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell | |
| AU5801399A | Method for predicting human cognitive performance |